V. BRYAN LAWLIS

Insider Reports History

Signature
/s/ Scott A. Samuels, Attorney-in-fact for V. Bryan Lawlis
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by V. BRYAN LAWLIS:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIOMARIN PHARMACEUTICAL INC Director Common Stock 33,140 $3,194,033 $96.38 23 May 2023 Direct
GERON CORP Director Common Stock 13,300 $15,667 $1.18 09 May 2025 Direct
GERON CORP Director Stock Option (right to buy) 180,000 21 May 2025 Direct
Aeglea BioTherapeutics, Inc. Director Director Stock Option (right to buy) 43,000 07 Jun 2022 Direct

Insider Reports Filed by V. BRYAN LAWLIS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GERN GERON CORP 21 May 2025 1 $0 4 Director 22 May 2025, 17:04
GERN GERON CORP 09 May 2025 1 $15,667 4 Director 13 May 2025, 16:20
GERN GERON CORP 15 May 2024 3 -$63,350 4 Director 17 May 2024, 16:05
GERN GERON CORP 09 May 2024 1 $0 4 Director 10 May 2024, 16:05
GERN GERON CORP 31 May 2023 1 $0 4 Director 02 Jun 2023, 19:32
BMRN BIOMARIN PHARMACEUTICAL INC 23 May 2023 1 $0 4 Director 24 May 2023, 18:27
GERN GERON CORP 11 May 2023 3 -$66,500 4 Director 11 May 2023, 21:01
BMRN BIOMARIN PHARMACEUTICAL INC 03 Apr 2023 3 -$248,880 4 Director 04 Apr 2023, 19:59
AGLE Aeglea BioTherapeutics, Inc. 07 Jun 2022 1 $0 4 Director 09 Jun 2022, 21:15
BMRN BIOMARIN PHARMACEUTICAL INC 24 May 2022 1 $0 4 Director 26 May 2022, 21:15
GERN GERON CORP 10 May 2022 1 $0 4 Director 11 May 2022, 18:16
BMRN BIOMARIN PHARMACEUTICAL INC 14 Apr 2022 3 -$196,350 4 Director 18 Apr 2022, 20:22
BMRN BIOMARIN PHARMACEUTICAL INC 14 Jan 2022 3 -$213,137 4 Director 19 Jan 2022, 17:34
AGLE Aeglea BioTherapeutics, Inc. 08 Jun 2021 1 $0 4 Director 09 Jun 2021, 17:23
BMRN BIOMARIN PHARMACEUTICAL INC 25 May 2021 1 $0 4 Director 27 May 2021, 19:02
GERN GERON CORP 11 May 2021 1 $0 4 Director 13 May 2021, 21:16